Fennec Pharmaceuticals Statistics

Total Valuation

TSX:FRX has a market cap or net worth of CAD 346.48 million. The enterprise value is 347.40 million.

Market Cap	346.48M
Enterprise Value	347.40M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	27.83M
Shares Outstanding	n/a
Shares Change (YoY)	-3.63%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	26.76
PS Ratio	7.63
PB Ratio	-34.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-21.16
EV / Sales	7.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.85

Current Ratio	4.85
Quick Ratio	4.30
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-11.20%
Return on Invested Capital (ROIC)	-28.57%
Return on Capital Employed (ROCE)	-26.54%
Revenue Per Employee	1.42M
Profits Per Employee	-513,024
Employee Count	32
Asset Turnover	0.62
Inventory Turnover	1.55

Taxes

In the past 12 months, TSX:FRX has paid 497,809 in taxes.

Income Tax	497,809
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.33% in the last 52 weeks. The beta is 0.59, so TSX:FRX's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+65.33%
50-Day Moving Average	11.79
200-Day Moving Average	9.76
Relative Strength Index (RSI)	57.52
Average Volume (20 Days)	1,001

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	19.23

Income Statement

In the last 12 months, TSX:FRX had revenue of CAD 45.42 million and -16.42 million in losses. Loss per share was -0.61.

Revenue	45.42M
Gross Profit	40.83M
Operating Income	-13.20M
Pretax Income	-15.92M
Net Income	-16.42M
EBITDA	-12.74M
EBIT	-13.20M
Loss Per Share	-0.61

Full Income Statement

Balance Sheet

The company has 25.51 million in cash and 26.41 million in debt, giving a net cash position of -898,784.

Cash & Cash Equivalents	25.51M
Total Debt	26.41M
Net Cash	-898,784
Net Cash Per Share	n/a
Equity (Book Value)	-10.18M
Book Value Per Share	-0.37
Working Capital	44.16M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-15.94M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 89.89%, with operating and profit margins of -29.06% and -36.14%.

Gross Margin	89.89%
Operating Margin	-29.06%
Pretax Margin	-35.05%
Profit Margin	-36.14%
EBITDA Margin	-28.05%
EBIT Margin	-29.06%
FCF Margin	n/a

Dividends & Yields

TSX:FRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.63%
Shareholder Yield	n/a
Earnings Yield	-4.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	0.3333333

Scores

TSX:FRX has an Altman Z-Score of -4.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.19
Piotroski F-Score	2